Area of research
Hematology · Molecular Biology
Research interest
Research interests include Medicine, Leukemia, Acute leukemia, Refractory (planetary science), Oncology, and Internal medicine.
Phase 1/2, multi-center, open-label clinical study to evaluate the safety, pharmacokinetics, and efficacy of zefamenib in patients with relapsed/refractory acute leukemia
A First-in-Human Phase 1/2 Study of the Menin-KMT2A(MLL1) Inhibitor BN104 in Adult Patients with Relapsed or Refractory Acute Leukemia